BMS signs $975m deal for Bavarian Nordic cancer vaccine

… license Bavarian Nordic's prostate cancer candidate Prostvac. BMS is paying … immune response against prostate cancer cells. Unlike Dendreon's prostate cancer vaccine Provenge … ready-to-use and does not require tumour cells from the patient to …